Publikationen von Philip Maximilian Knaff
Alle Typen
Zeitschriftenartikel (4)
Zeitschriftenartikel
5 (1), 681 (2022)
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture. Communications Biology
Zeitschriftenartikel
29 (4), S. 635 - 665 (2022)
Interface with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy. Current Medicinal Chemistry
Zeitschriftenartikel
12, 1726 (2021)
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nature Communications
Zeitschriftenartikel
21 (4), S. 1636 - 1643 (2020)
From In Silico to Experimental Validation: Tailoring Peptide Substrates for a Serine Protease. Biomacromolecules Hochschulschrift - Doktorarbeit (1)
Hochschulschrift - Doktorarbeit
Development of Peptidomimetic Substrates and Inhibitors for Transmembrane Serine Proteases. Dissertation, Johannes Gutenberg-Universität, Mainz (2021)
Patent (1)
Patent
SELECTIVE TMPRSS2 INHIBITORS AND MEDICAL USE THEREOF. (2021)